Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06685458

Constructing a Predictive Model for Differentiating Between Benign and Malignant Solid Pulmonary Nodules Based on Clinical and Imaging Features.

Combined With Clinical and Imaging Features, the Prediction Model of Benign and Malignant Solid Pulmonary Nodules Was Constructed

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
320 (estimated)
Sponsor
The Third Affiliated Hospital of Kunming Medical College. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study Objective: To comprehensively analyze the preoperative clinical and imaging characteristics of solid pulmonary nodules, investigate the risk factors associated with malignant solid pulmonary nodules, and provide a reference for preoperative treatment decisions. Significance of the Study: According to the 2020 Global Cancer Report, lung cancer remains the leading cause of cancer-related deaths worldwide. While the majority of patients with stage I lung cancer achieve long-term survival, survival rates for advanced-stage patients are extremely low. Early screening, diagnosis, and treatment of lung cancer are crucial. With the widespread implementation of early lung cancer screening, a growing number of pulmonary nodules are being detected, among which solid pulmonary nodules constitute a significant proportion. Unlike ground-glass nodules, accurately distinguishing between benign and malignant solid nodules is critical for determining appropriate treatment strategies. For benign solid nodules, follow-up observation is the preferred approach, whereas early surgical intervention is essential for malignant solid nodules. Although previous studies have explored the correlation between clinical and imaging characteristics, they have not conducted systematic analyses, and most have been based on small sample sizes. Therefore, this study aims to conduct a comprehensive analysis of preoperative clinical and imaging characteristics, build a predictive model to differentiate between benign and malignant solid pulmonary nodules, and provide a reliable reference for selecting treatment strategies.

Detailed description

Our study evaluate patients with SPN from the Third Affiliated Hospital of Kunming Medical University. The patient selection followed specific inclusion and exclusion criteria. Inclusion criteria included: (1) All subjects provided CT imaging obtained from the Third Affiliated Hospital of Kunming Medical University within 2-week period prior to surgery; (2) Complete clinicopathological data of solid nodules were obtained; (3) Surgical intervention for one or more SPN; (4) No prior anti-tumor treatments like radiotherapy or chemotherapy; (5) Age 18 years or older. Exclusion criteria involved: (1) Patients with incomplete imaging data or medical records; (2) Lung infections that could affect image analysis; (3) Significant respiratory movement artifacts in images impairing imaging analysis; (4) Inconsistent locations of SPN in postoperative pathology reports and preoperative CT images.

Conditions

Interventions

TypeNameDescription
OTHERPreoperative Clinical and Imaging Feature Evaluation for Predictive ModelingThis study involves preoperative evaluation of clinical and imaging features for constructing a predictive model to differentiate benign and malignant solid pulmonary nodules. Surgical resection is performed to obtain pathological confirmation as the reference standard.

Timeline

Start date
2024-11-15
Primary completion
2025-01-30
Completion
2025-02-20
First posted
2024-11-12
Last updated
2024-11-12

Source: ClinicalTrials.gov record NCT06685458. Inclusion in this directory is not an endorsement.